GlassScriptPhysician profile
Laura J Burpee
NPI 1386826071
$1,275.68
in general payments reported to CMS, 2019-2025
19 companies · $42.32 in 2025
The $42.32 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $39.83 · 2023: $754 · 2024: $284 · 2025: $42.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $263.03 | 2021-2023 | Biomonitor, Acticor 7 Vr-T Dx, Selectra |
| Novartis Pharmaceuticals Corporation | $152.58 | 2023-2025 | |
| Celgene Corporation | $151.92 | 2023-2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $135.66 | 2023-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.07 | 2023-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $85.15 | 2023-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.90 | 2022-2024 | Lifevest |
| Amgen INC. | $43.10 | 2023-2024 | Repatha |
| Irhythm Technologies, INC. | $36.30 | 2024 | Zio Xt Patch, Zio Monitor |
| Janssen Pharmaceuticals, INC | $36.28 | 2023 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $33.94 | 2023 | Inpefa |
| Boston Scientific Corporation | $31.67 | 2021-2022 | |
| Medicomp INC | $24.09 | 2023 | Telepatch Cardiac Monitor |
| Medtronic, INC. | $19.18 | 2024 | Micra |
| Alnylam Pharmaceuticals INC. | $18.99 | 2025 | Amvuttra |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.52 | 2023 | |
| Ablative Solutions, INC. | $18.23 | 2021 | |
| Novo Nordisk INC | $18.05 | 2023 | Ozempic |
| Edwards Lifesciences Corporation | $17.02 | 2024 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Burpee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.